Friday, August 18, 2017

Opioids

U.S._Capitol_Building

AIPM Response to Draft Report from President’s Opioid Commission

After multiple delays, the President’s Commission on Combating Drug Addiction and the Opioid Crisis released its draft report on Monday, July 31st, proposing well over a dozen possible steps that the President could take to address addiction to, and misuse of, opioids. As a pain management organization focused on the importance of integrative care and

opana_feat

AIPM’s Response to FDA’s Request to Pull Opana ER Off Market

On Thursday, June 8, the U.S. Food and Drug Administration “requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market,” the FDA said in a statement. Apparently Opana ER, an extended release form of the opioid drug oxymorphone, was being crushed up and injected by people seeking to

Naturapathic_feat

AIPM Executive Director to Speak at Chronic Pain Seminar in April

AIPM’s Executive Director Bob Twillman, PhD, will be a speaker at a seminar entitled, “Natural Approaches to Chronic Pain: Effective Alternatives to Opioids,” on Saturday, April 29 from 8 am – 2 pm at the Hyatt Regency Crystal City in Arlington, Virginia. Through a joint providership with the American Association of Naturopathic Physicians, the Academy

Older Posts››